Canadian patent law not a dramatic change, rules Eli Lilly tribunal
The NAFTA tribunal in Eli Lilly v Canada found that a recently developed "promise utility doctrine" in Canadian jurisprudence on pharmaceutical patents did not represent a dramatic change from previous Canadian law, the newly published award reveals.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.